The World Health Organization has published information for COVID-19 researchers looking at antibodies in previously infected individuals to help gain a picture of community spread, the possibility of catching the novel virus twice, and to track other characteristics of the disease. If you or a company or research team you know is working on COVID-19 research, the following information may be useful as it is linked to more resources and related guidelines. Also, if you are not already following this page, this is where WHO publishes guidelines for a number of rapidly evolving aggregated studies and guidelines for COVID-19 response. We hope it is helpful to you.
University of Michigan startup Arbor Biosciences announced this afternoon that it is providing free kits to capture the genetic code of virus samples for researchers working on COVID-19 sequencing. According to a press release sent out by the University of Mchigan, “variations in the virus’s genetic code reveal how the virus has morphed over time—for instance, enabling it to change from an animal disease to one that can be passed from one human to another. The information could help shed light on how the genes of the virus, SARS-CoV-2, cause the symptoms of the disease COVID-19. But more important in the long run, it could help reveal the factors that enabled the virus to become infectious in humans.”